Skip to main content

Epitalon: Benefits, side effects, dosage details, and how it works

We examine how the peptide epitalon works for aging, menopause, sleep health, metabolism, and other health concerns.

by
Last updated: Jun 27th, 2025
Epitalon Upper Image

Photo by Innerbody Research

Aging has its upsides, certainly, but we can’t deny the health changes that come with every pass around the sun. For many of us, sleep isn’t like it used to be, neither is our metabolism, and our physio-emotional circuits get all messed up.

A catch-all answer to these and other health troubles could lie in a therapeutic peptide called epitalon. Based on an animal-derived pineal polypeptide extract, epitalon has a clinical pedigree stretching back several decades, with the last 25 years seeing extensive studies in vitro, in vivo, and in silico. In this guide, we present the broad body of research behind epitalon, discuss its potential benefits, and help you understand the place epitalon could potentially have in a health regimen.

Jump to

Jump to:

Why you should trust us

Over the past two decades, Innerbody Research has helped tens of millions of readers make more informed decisions about staying healthy and living healthier lifestyles.

For years, we’ve dedicated over 1,000 cumulative hours to researching therapeutic peptides. We add to the total just about every week, and it will have increased much further by the time you read this. Thus, our knowledge of the subject has grown continuously. Epitalon alone represents around 50 hours of research-seeking, close reading, and fact-checking. That’s without accounting for the unclocked time we spent consulting with healthcare providers who prescribe peptides, to better understand where epitalon stands on the therapeutic landscape.

Additionally, like all health-related content on this website, this guide was thoroughly vetted by one or more members of our Medical Review Board for accuracy and will continue to be monitored for updates by our editorial team.

What is epitalon?

Epitalon (a.k.a. epithalon and epithalone) is a therapeutic tetrapeptide consisting of the amino acids alanine, glutamic acid, aspartic acid, and glycine. As a natural peptide, it’s isolated from epithalamin, a polypeptide produced in bovine pineal glands. It can also be lab-synthesized.

Insider Tip: The terms tetrapeptide and polypeptide refer to two types of peptide bonds. Tetrapeptides consist of four amino acids, whereas polypeptides have more than 20 amino acids. Moreover, smaller-chain peptides like tetrapeptides are more easily absorbed by the body.

Epitalon is believed to be the active fragment of epithalamin, which researchers have studied for its effects on aging and longevity. In 2003, for example, a multi-year study published in Neuroendocrinology Letters found that epithalamin could “normalize the basic functions of the human organism,” potentially extending lifespan by improving cardiovascular, endocrine, immune, and nervous function, as well as homeostasis and metabolism. Several publications — including two systematic reviews in Advances in Gerontology — have corroborated such findings.

Researchers believe that epitalon’s therapeutic qualities may be due to the following mechanisms of action:

Telomere elongation

Telomeres are “caps” of DNA sequences at the ends of chromosomes. Think of them as chromosomal shoelace aglets, protecting the ends from damage. But telomeres are finite. They shorten every time a cell divides, until they become too short to allow proper cell division. Consequently, the cell dies.

Epitalon appears to slow the natural course toward cell death by increasing the activity of an enzyme called telomerase. This enzyme adds DNA to telomeres, giving them more length to promote healthy cell division. Epitalon, then, may help keep your cells alive.

Melatonin regulation

Melatonin, a hormone most commonly associated with sleep, is also linked to the aging process. The authors of a 2022 review described the relationship as a “vicious cycle”: melatonin synthesis decreases as you grow older, and the aging process worsens because of melatonin deficiency. The worsening is due to the correlation between reduced melatonin levels and pathologies such as Alzheimer’s onset, menopause severity, and cardiovascular disorders.

Melatonin comes from the pineal gland, epitalon is a pineal gland peptide, and clinical research points to a close relationship between the two. For example, an in vitro study from 2013 saw that rat cells treated with epitalon exhibited statistically significant increases in biomarkers associated with melatonin, suggesting the peptide has a direct effect on melatonin synthesis. Thus, epitalon helps keep your body in supply of a hormone necessary to stave off age-related diseases.

Interleukin-2 production

Interleukin-2 is a type of signaling protein that’s critical to proper immune function. As with telomeres and melatonin, your body has less interleukin-2 the older you get. This age-linked decline corresponds to decreased immunologic function and the onset of disease.

Epitalon may help counteract your natural interleukin-2 decline by activating interleukin-2 mRNA synthesis, as explained by the researchers behind a 2002 in vitro study on mouse cells. And its effect appears to be faster than that of other therapeutic peptides, elevating interleukin-2 mRNA levels in just five hours compared to vilon's and cortagen’s 20 hours.

Current therapeutic uses of epitalon

Studies suggest that epitalon’s actions on telomeres, melatonin, and interleukin-2 can yield health benefits related to the human lifespan. Much of the clinical research has been done in rodent cells and models, but there have also been human trials to indicate epitalon’s use as a longevity treatment. Below, we discuss the most common therapeutic applications of epitalon and the science to support them.

Antiaging

Epitalon’s telomere-lengthening capability may be its key to countering cellular senescence. Defined as the state in which a cell stops reproducing, cellular senescence is associated with many of the health troubles we associate with advanced age — dementia, arthritis, and cardiovascular diseases — and shortened telomeres may be its main contributing factor. In theory, by lengthening your telomeres with epitalon, you could increase your cellular lifespan and, therefore, ward off the deleterious effects of growing older.

Epitalon has demonstrated life-extending outcomes in practice as well. For example, in a 2003 study in mice, treatment with epitalon decreased the frequency of chromosome aberrations in bone marrow cells associated with age-related diseases such as acute myeloid leukemia and myelodysplastic syndrome. (In humans, these diseases primarily affect people who are over the age of 45, and more commonly those who are 65 or older.) By the study’s end, epitalon increased the lifespans of the last 10% of survivors by 13.3%. To top things off, epitalon happens to have antioxidant properties, which means it can help mitigate the oxidative stress induced by reactive oxygen species, one of the chief causative factors of cellular senescence.

Improved sleep health

In a 2021 human trial involving 75 women, 0.5mg of epitalon per day was found to increase melatonin synthesis by 160% compared to placebo. That has positive implications for sleep health because melatonin — a hormone whose levels decrease with age — helps control when and how well you sleep. In turn, improved sleep health itself has positive implications for epitalon’s other therapeutic uses, as longer and higher-quality slumber is linked to better immune function, lower rates of age-related diseases (including cancer), and longer lifespans. That isn’t to say that an epitalon dose will knock you out, only that it can help optimize your circadian rhythm.

Improved immune function

Telomeres and melatonin are both star players in your immune system. As suggested by Dr. Mary Armonios of the Johns Hopkins Kimmel Cancer Center, maintaining normal telomere length is inversely correlated with immune system abnormalities, and a 2013 review notes that melatonin modulates immune responses by helping to proliferate immunocompetent cells and secrete immune mediators.

Tumor suppression

The telomere-lengthening, along with the attendant increase in immune function, may help ward off cancer as well. For example, in a 2002 study in cancer-induced rats, subjects who received five subcutaneous epitalon injections per week were found to have smaller and fewer tumors than their control-group counterparts. Similar outcomes came out of a separate study in mice published in the same year.

Other benefits of epitalon

Improvements in one area of your health are liable to cascade into other improvements in related areas. That, in turn, can lead to further improvements downstream. And when you’re talking about changes to such major processes as aging, immunity, and sleep, the subsequent effects can be similarly significant — for example:

  • Cardiovascular health: In 2004, the American Heart Association described telomere dysfunction as an “important factor in the pathogenesis of hypertension, atherosclerosis, and heart failure,” a claim that has been borne out in research since. Poor sleep is also linked to cardiovascular risk factors like high blood pressure and diabetes, so epitalon’s actions on telomere length and sleep may affect two aspects of healthy heart maintenance.
  • Hormone regulation: In addition to in vitro and in vivo studies showing that epitalon may directly improve hormone levels, the peptide’s effect on melatonin production suggests that it can improve the experience of hormone-related processes such as menopause, as melatonin supplementation has demonstrated an ability to alleviate menopausal symptoms.
  • Better skin: Skin cells are susceptible to accelerated telomere shortening because of their high rate of replication and exposure to damaging agents. Therefore, maintaining telomere length in the skin can slow down the process that results in visible signs of aging, like wrinkles.
  • Improved energy, mood, cognitive function, and stress: Epitalon promotes melatonin production. More melatonin means more sleep signals, which correlate with higher energy levels and better mood, both of which can lead to improved executive function and stress resilience.

Is epitalon safe?

Epitalon appears broadly safe for human use, but critical safety testing is lacking even with the peptide’s relatively long research timeline.

In 2015, a Cognitive Vitality Report released by the Alzheimer’s Drug Discovery Foundation stated that two multi-year treatment trials had found that epithalamin, from which epitalon is isolated, had imparted no severe adverse events in older adults, and that preclinical trials supported a “favorable safety profile.” Ten years later, a systematic review published in 2025 states that “information regarding critical issues about this peptide’s safety is missing.” In terms of human trials, the best case we have in support of epitalon’s safety is a 2002 trial involving 162 patients in which nobody in the epitalon group reported serious side effects.

At the same time, the U.S. Food & Drug Administration (FDA) includes epitalon in its group of peptides that pose a risk of immunogenicity, in which the body reacts to a substance as though it were a threat and mounts an immune response against it. The FDA warns that such immune responses can be life-threatening, so epitalon isn’t completely safe for everyone.

In addition, the healthcare providers we’ve consulted with suggest that women who are pregnant or breastfeeding should avoid epitalon, along with other therapeutic peptides, since there isn’t enough research to confirm safety for them or their fetus/child. They also caution that people with active or suspected cancer should get the go-ahead from their doctor before using epitalon — that is, should it become available as an approved prescription.

Research-grade vs. pharmaceutical-grade epitalon

Currently, epitalon is not available as a pharmaceutical-grade prescription in the United States. Therefore, the only epitalon on the market is research-grade, which is not suitable for human consumption or use.

Because all epitalon is now research-grade, you can probably find it online and purchase it without a prescription, but we caution against doing so. Research-grade peptides aren’t subject to the same quality controls as their pharmaceutical-grade counterparts, so you could end up with a medicine with a dangerously low purity that increases the risk of adverse events, including immunogenicity.

What’s it like to use epitalon?

Even though epitalon isn’t publicly available as a pharmaceutical-grade prescription, clinicians who’ve prescribed it in the past have given us valuable insight into how it’s dosed and administered, as well as the timeline of benefits users can expect to experience.

Dosing and administration of epitalon

A standard dose of epitalon is 1mg per injection, although exact dosing may depend on variables such as your age, weight, and existing health conditions.

Like many other therapeutic peptides, epitalon normally comes as a reconstitutable powder in a vial, along with supplies you need to mix and administer your doses — bacteriostatic water, needle syringes, and alcohol swabs. Your peptide should come with instructions on how to properly reconstitute the powder, but the gist of it is that you add bacteriostatic water to the vial to dissolve it.

The dosing protocol is five injections per week into an area of subcutaneous fat, such as an arm, a thigh, or your belly. Because of epitalon’s action on melatonin production, nighttime administration is ideal.

Like many therapeutic peptides, epitalon is typically cycled, which means using the drug for a specific period and then taking a break from it. A common epitalon cycle is one month on followed by three months off — a total of three cycles per year.

Timeline of benefits from epitalon

Sleep benefits are likely to be the first effects that users feel, arising within the first 1-2 weeks of use. Along with those sleep benefits may come attendant improvements in energy, mood, cognitive function, and stress. In weeks 4-6, users may notice improved skin health, as well as the effects of reduced oxidative stress. Then weeks 8-12 should bring less apparent but deeply important benefits related to longevity, such as improved immune function and cellular health. These latter health benefits, as well as associated improvements in cardiovascular and cognitive function, should continue with longer-term use.

Storing epitalon

Reconstitutable peptides normally come in a month’s supply, so users must store the remainder under controlled conditions to preserve therapeutic integrity. The U.K.’s National Institute for Biological Standards and Control recommends storing leftover peptides at around 4°C, or 39°F, so a refrigerator is the ideal storage container.

Who is (and isn’t) a candidate for epitalon?

Because epitalon’s primary therapeutic uses relate to aging and age-related health conditions, it’s best suited for people who’ve begun to exhibit signs of cellular and biological aging. Broadly speaking, 40 years old is the Rubicon, as that’s when people tend to see declines in their melatonin levels, and their telomere lengths have become significantly shortened. But 40 is only an approximate milestone. Some people may begin to exhibit the signs of aging earlier or later.

As for people who should not use epitalon, all we know for sure is that they include women who are pregnant or breastfeeding, as there isn’t enough research to confirm the safety of the mother, their fetus, or their developing child. Additionally, the healthcare providers we consulted recommend that people with an active or suspected cancer diagnosis speak with their doctor to confirm whether epitalon is appropriate for them.

Where to find epitalon

As of this writing, pharmaceutical-grade epitalon can’t be prescribed in the United States. Only the research-grade alternative is available, including through online retailers. But given the risk of potentially life-threatening toxicity and immunogenicity, we caution against putting research-grade peptides into your body.

Epitalon’s availability status may eventually change; it depends on what the FDA decides about its safety profile. We’ll be monitoring the peptide space in the meantime and will update this guide accordingly.

43

Sources

Innerbody uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.

  1. Araj, S. K., et al. (2025). Overview of epitalon — highly bioactive pineal tetrapeptide with promising properties. International Journal of Molecular Sciences, 26(6), 2691.

  2. Khavinson, V. K., & Morozov, V. G. (2003). Peptides of pineal gland and thymus prolong human life. Neuroendocrinology Letters, 24(3/4), 233-240.

  3. Linkova, N.S., et al. (2011). Influence of peptides from pineal gland on thymus function with aging. Advances in Gerontology, 1, 240-243.

  4. Khavinson, V. K., Kuznik, B. I., & Ryzhak, G. A. (2011). Peptide bioregulators: The new class of geroprotectors. Message 2. Clinical studies results. Advances in Gerontology, 26(1), 20-37.

  5. National Human Genome Research Institute. (2025). Telomere. NHGRI.

  6. National Cancer Institute. (n.d.). Telomerase. NCI.

  7. Martín Giménez, V. M., et al. (2022). Melatonin as an anti-aging therapy for age-related cardiovascular and neurodegenerative diseases. Frontiers in Aging Neuroscience, 14, 888292.

  8. Khavinson, V. K., et al. (2012). Molecular cellular mechanisms of peptide regulation of melatonin synthesis in pinealocyte culture. Bulletin of Experimental Biology and Medicine, 153(2), 255-258.

  9. National Cancer Institute. (n.d.). Interleukin-2. NCI.

  10. Pahlavani, M. A., & Richardson, A. (1996). The effect of age on the expression of interleukin-2. Mechanisms of Ageing and Development, 89(3), 125-154.

  11. Kazakova, K., et al. (2002). In vitro effect of short peptides on expression of interleukin-2 gene in splenocytes. Bulletin of Experimental Biology and Medicine, 133, 614-616.

  12. Di Micco, R., Krizhanovsky, V., & Baker, D. (2021). Cellular senescence in ageing: From mechanisms to therapeutic opportunities. Nature Reviews Molecular Cell Biology, 22(2), 75-95.

  13. Hamazaki, J., & Murata, S. (2024). Relationships between protein degradation, cellular senescence, and organismal aging. The Journal of Biochemistry, 175(5), 473-480.

  14. Anisimov, V. N., et al. (2003). Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology, 4, 193-202.

  15. American Cancer Society. (2025). Key statistics for acute myeloid leukemia (AML). ACA.

  16. Lopez, M. A. (2023). Myelodysplastic syndromes (MDS). Rare Disease Advisor.

  17. Kozina, L., Arutjunyan, A., & Khavinson, V. (2007). Antioxidant properties of geroprotective peptides of the pineal gland. Archives of Gerontology and Geriatrics, 44, 213-216.

  18. Johns Hopkins Medicine. (2019). Immune cells age and die prematurely in people with very short telomeres, according to new study. Johns Hopkins Medicine.

  19. Carrillo-Vico, A., et al. (2013). Melatonin: Buffering the immune system. International Journal of Molecular Sciences, 14(4), 8638-8683.

  20. Anisimov, V. N., et al. (2002). Inhibitory effect of peptide epitalon on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats. Cancer Letters, 183(1), 1-8.

  21. Anisimov, V. N., et al. (2002). Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. International Journal of Cancer, 101(1), 7-10.

  22. Ivko, O. M., et al. (2021). AEDG peptide regulation of the expression of human circadian rhythm genes upon accelerated aging of the pineal gland. Advances in Gerontology, 11, 53-58.

  23. Mayo Clinic Staff. (2023). Melatonin. Mayo Clinic.

  24. Luyster, F. S., Zee, P. C., & Walsh, J. K. (2012). Sleep: A health imperative. Sleep, 35(6), 727-734.

  25. Serrano, A. L., & Andrés, V. (2004). Telomeres and cardiovascular disease: Does size matter? Circulation Research, 94(5).

  26. Hoffmann, J., et al. (2021). Telomerase as a therapeutic target in cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 41(3).

  27. American Heart Association. (2023). Sleep disorders and heart health. AHA.

  28. Yue, X., et al. (2022). Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro. Aging, 14(7), 3191-3202.

  29. University of Utah Health. (2021). Menopause and melatonin. University of Utah Health.

  30. Buckingham, E. M., & Klingelhutz, A. J. (2011). The role of telomeres in the ageing of human skin. Experimental Dermatology, 20(4), 297-302.

  31. Harvard Medical School. (2025). How sleep boosts your energy. Harvard Health Publishing.

  32. Harvard Medical School. (2021). Sleep and mood. Harvard Medical School Division of Sleep Medicine.

  33. Lindert, J., et al. (2021). Depression, anxiety, and anger and cognitive functions: Findings from a longitudinal prospective study. Frontiers in Psychiatry, 12, 665742.

  34. McEwen, B. S. (2017). Neurobiological and systemic effects of chronic stress. Chronic Stress, 1, 2470547017692328.

  35. Alzheimer’s Drug Discovery Foundation. (2015). Epithalamin/Epithalon. ADDF.

  36. Khavinson V.K., et al. (2002). Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa. Neuroendocrinology Letters, 23, 365-368.

  37. U.S. Food & Drug Administration. (2024). Certain bulk drug substances for use in compounding that may present significant safety risks. FDA.

  38. U.S. Food & Drug Administration. (2024). Immunogenicity of protein-based therapeutics. FDA.

  39. De Groot, A. S., et al. (2023). Immunogenicity risk assessment of synthetic peptide drugs and their impurities. Drug Discovery Today, 28(10), 103714.

  40. National Institute for Biological Standards and Control. (n.d.). Peptide handling, dissolution & storage. NIBSC.

  41. Cleveland Clinic. (2025). Melatonin. Cleveland Clinic.

  42. Chilton, W., & Charchar, F. (2017). Telomeres, aging and exercise: Guilty by association? International Journal of Molecular Sciences, 18(12), 2573.

  43. Tanabe, S., et al. (1991). Nutritional effects of an oligopeptide mixture with a very high fischer ratio on the amino acid absorption and cerebral amine metabolism in rats suffering from galactosamine-induced liver injury. Agricultural and Biological Chemistry, 55(10), 2585-2590.